Accuracy of plasma cell-free DNA PCR versus mNGS for non-invasive diagnosis of invasive mold disease
Open Access
- 2 November 2026
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
Abstract
Cell-free DNA (cfDNA) detection in plasma is a novel testing modality for non-invasive diagnosis of invasive mold disease (IMD) in immunocompromised patients. The accuracy of PCR compared to metagenomic next-generation sequencing (mNGS) for diagnosis of IMD remains unknown. Plasma samples from patients with proven and probable IMD and no IMD were tested with mold PCR and shotgun mNGS. Mold PCR detected Aspergillus species, Mucorales agents, Fusarium species, Scedosporium species, and Lomentospora prolificans . The sensitivity and specificity of mold PCR and mNGS were measured. Ninety-four patients with proven (48) and probable (48) IMD due to Aspergillus species (64), Mucorales agents (13), Scedosporium species and Lomentospora prolificans (13), and Fusarium species (6), and 62 patients with no IMD were included in this study. 99.4% (155) of the patients were immunosuppressed. The overall sensitivity and specificity were 62.5% (60/96; 95% CI 52.0–72.2) and 99.8% (535/536; 95% CI 99.0–100), respectively, for mold PCR and 43.8% (42/96; 95% CI 33.6–54.3; P < 0.001) and 99.6% (534/536; 95% CI 98.7–100; P = 1.0), respectively, for mNGS. The proportion of mold PCR-positive mNGS-negative results was 16.0% (4/25) in focal cases compared with 25.0% (11/44; P = 0.384) and 18.5% (5/27; P = 0.810) in multifocal and disseminated cases, respectively. The median PCR cycle threshold was 40.6 (IQR, 37.5–41.5) in PCR-positive mNGS-negative cases compared with 37.3 (IQR, 34.5–39.3; P = 0.004) in PCR-positive mNGS-positive cases. Plasma cfDNA PCR is more sensitive than mNGS for the diagnosis of IMD in immunocompromised patients. Lower sensitivity of mNGS was associated with lower mold cfDNA burden. IMPORTANCE: Invasive mold disease (IMD) is a major cause of morbidity and mortality in immunocompromised patients. Early diagnosis and initiation of tailored antifungal therapy are critical for optimizing outcomes in patients with IMD. Detection of circulating fungal cell-free DNA (cfDNA) in the acellular fraction of blood is a novel testing modality that is increasingly used for early and non-invasive diagnosis of IMD. This study represents the first head-to-head accuracy study to compare the sensitivity and specificity of PCR with mNGS for the diagnosis of IMD. The study showed that the overall mold PCR was significantly more sensitive compared with mNGS, while both assays demonstrated very high specificity. Similar trends were observed in a smaller subgroup of patients with invasive aspergillosis, mucormycosis, and scedosporiosis. The findings have implications for assay selection when seeking to non-invasively diagnose IMD in immunocompromised patients.Keywords
This publication has 26 references indexed in Scilit:
- Diagnostic value of plasma cell-free DNA metagenomic next-generation sequencing in patients with suspected infections and exploration of clinical scenarios—a retrospective study from a single centerAnnals of Medicine, 2026
- Superior Accuracy of Aspergillus Plasma Cell-Free DNA Polymerase Chain Reaction Over Serum Galactomannan for the Diagnosis of Invasive AspergillosisClinical Infectious Diseases, 2023
- Clinical evaluation of cell-free and cellular metagenomic next-generation sequencing of infected body fluidsJournal of Advanced Research, 2023
- Clinical Accuracy and Impact of Plasma Cell-Free DNA Fungal Polymerase Chain Reaction Panel for Noninvasive Diagnosis of Fungal InfectionClinical Infectious Diseases, 2021
- Liquid Biopsy for Invasive Mold Infections in Hematopoietic Cell Transplant Recipients With Pneumonia Through Next-Generation Sequencing of Microbial Cell-Free DNA in PlasmaClinical Infectious Diseases, 2020
- Clinical metagenomicsNature Reviews Genetics, 2019
- Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious diseaseNature Microbiology, 2019
- Emerging infections caused by non- Aspergillus filamentous fungiClinical Microbiology and Infection, 2016
- Invasive Fungal Pathogens: Current Epidemiological TrendsClinical Infectious Diseases, 2006
- The invasive and saprophytic syndromes due toAspergillusspp.Medical Mycology, 2005